Literature DB >> 9164671

Central nervous system complications of diabetes mellitus--a perspective from the blood-brain barrier.

A D Mooradian1.   

Abstract

A host of diabetes-related changes in the central nervous system (CNS) has been recognized. The underlying causes of these changes are multiple. An important contributor to the changes in the CNS is the blood-brain barrier (BBB). Diabetes is associated with changes in both the barrier and transport functions of the cerebral microvessels. Structural changes in cerebral microvessels may account for some of the observed changes. Additional mechanisms include alterations in hemodynamic variables such as arteriovenous shunting, changes in biophysical properties and biochemical compositions of the endothelial cells including changes in lipid fluidity and composition, and alterations of neurotransmitter activity in the cerebral microvessels, notably altered beta adrenergic neurotransmission. These observations indicate that the CNS is not immune against the microangiopathic complications commonly found in various tissues of diabetic animals.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9164671     DOI: 10.1016/s0165-0173(97)00003-9

Source DB:  PubMed          Journal:  Brain Res Brain Res Rev


  38 in total

Review 1.  Is Alzheimer's disease amyloidosis the result of a repair mechanism gone astray?

Authors:  Tyler A Kokjohn; Chera L Maarouf; Alex E Roher
Journal:  Alzheimers Dement       Date:  2011-11-02       Impact factor: 21.566

Review 2.  Metabolic Alterations Associated to Brain Dysfunction in Diabetes.

Authors:  João M N Duarte
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

Review 3.  Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures.

Authors:  Niall Patton; Tariq Aslam; Thomas Macgillivray; Alison Pattie; Ian J Deary; Baljean Dhillon
Journal:  J Anat       Date:  2005-04       Impact factor: 2.610

4.  Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology.

Authors:  Michal Schnaider Beeri; Jeremy M Silverman; Kenneth L Davis; Deborah Marin; Hillel Z Grossman; James Schmeidler; Dushyant P Purohit; Daniel P Perl; Michael Davidson; Richard C Mohs; Vahram Haroutunian
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2005-04       Impact factor: 6.053

Review 5.  Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?

Authors:  Kawser Akter; Emily A Lanza; Stephen A Martin; Natalie Myronyuk; Melanie Rua; Robert B Raffa
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

6.  Immunogold study of altered expression of some interendothelial junctional molecules in the brain blood microvessels of diabetic scrapie-infected mice.

Authors:  Andrzej W Vorbrodt; Danuta H Dobrogowska; Michal Tarnawski; Harry C Meeker; Richard I Carp
Journal:  J Mol Histol       Date:  2006-08-22       Impact factor: 2.611

7.  Role of age-related decrease of renal organic cation transporter 2 in the effect of atenolol on renal excretion of metformin in rats.

Authors:  Jiangxia Ren; Yan Zhou; Guoqiang Zhang; Liting Zhou; Jing Zhao; Yuhui Wei; Xin'an Wu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-07-01       Impact factor: 2.441

Review 8.  Type 2 diabetes and risk of cognitive impairment and dementia.

Authors:  Rachel A Whitmer
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

Review 9.  Diabetes, adult neurogenesis and brain remodeling: New insights from rodent and zebrafish models.

Authors:  Anne-Claire Dorsemans; David Couret; Anaïs Hoarau; Olivier Meilhac; Christian Lefebvre d'Hellencourt; Nicolas Diotel
Journal:  Neurogenesis (Austin)       Date:  2017-01-31

10.  Early changes in physiological variables after stroke.

Authors:  Andrew A Wong; Stephen J Read
Journal:  Ann Indian Acad Neurol       Date:  2008-10       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.